Webinars

Past Webinars


Webinar Date:
Jessica Gill, PhD, RN, from the National Institute of Health, presented her research on the role of proteomic biomarkers of brain injuries at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Danielle Graham, PhD from Biogen presented on accelerating exploratory fluid biomarker assay development in neurodegenerative disease at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Cheryl Wellington, PhD from the University of British Columbia, presented on the functional modeling of the human cerebrovasculature at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Rama Boyanapalli, PhD from Shire Pharmaceuticals presented novel research on the long and winding road to a highly sensitive RANKL Assay at the inaugural Powering Precision Health Summit 2016.                           
Webinar Date:
Ralph McDade, PhD from Myriad RBM presented a triphase approach to biomarker pattern discovery for cancer immunotherapy and autoimmune disease at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
John Yan, PhD, from Takeda Pharmaceutical Company presented an ultrasensitive assay format for detecting PD biomarkers in cell and xenograft tumors at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
This webinar describes a groundbreaking new technique published recently in Analytical Chemistry for measuring single cancer cells. The study, conducted by Dr. David Walt and his research group at Tufts University, demonstrates that the ultrasensitive Simoa technology makes it possible to quantify…
Webinar Date:
We describe the use of single molecule arrays (Simoa) for the multiplex detection of proteins at very low concentrations in this webinar. We also provide an overview of the Simoa technology - which is capable of providing a 1000-fold improvement in sensitivity to proteins over conventional assays.
Webinar Date:
Learn how the Institut Pasteur has used the Quanterix Simoa HD-1 Analyzer and Simoa homebrew assays to make advances in their research.
Webinar Date:
TBIs are common in military personnel and civilians, placing these individuals at high risk for neurological deficits. The reasons why some individuals are at higher risk for these symptoms and deficits remains largely unknown. This webinar explores the topic further.